The detection of immatire platelet fraction for predicting the recovery from thrombocytopenia after chemotherapy: a prospective observation study.

The detection of immatire platelet fraction for predicting the recovery from thrombocytopenia after chemotherapy: a prospective observation study. - The detection of immatire platelet fraction for predicting the recovery from thrombocytopenia after chemotherapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008223

Enrollment

100

Registered

2012-07-01

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who have solid tumor. 2) Patients who are undergoing chemotherapy with myelosuppressive agents. 3) Patients who are over 18 years of age. 4) Patients who have given written informed consent.

Exclusion criteria

Exclusion criteria: 1) Hemorrhagic and thrombotic disorders 2) Disseminated intravascular coagulation 3) Bone marrow failure 4) Secondary hematopoietic disorders 5) Secondary platelet aggregation 6) Patients considered ineligible for this study

Design outcomes

Primary

Measure	Time frame
The recovery from thrombocytopenia	—

Countries

Japan

Contacts

Public ContactEmi Noguchi

National Cancer Center Hospital Breast and Medical Oncology

enoguchi@ncc.go.jp03-3542-2511

Outcome results